Armodafinil (Nuvigil)
What to know about Armodafinil — also sold as Nuvigil: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Armodafinil (brand names: Nuvigil) is classified as Moderate risk (4 risk points) by AllMeds. It is a S8 medication under the TGA in Australia. S8 stimulant with high abuse potential and significant CNS effects requiring monitoring.
Key Takeaways
- TGA Schedule: S8 in Australia
- Risk level: Moderate (4 points)
- SIRA reportable: Flagged for NSW workers compensation reporting
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S8 | PBS listed |
Risk Profile
S8 stimulant with high abuse potential and significant CNS effects requiring monitoring.
How Armodafinil is regulated
Armodafinil is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as S8 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Flagged as reportable under SIRA guidelines in NSW. Claims involving this medication may require additional reporting and clinical justification.
Check this medication against your full medication list
Run a full risk assessment including Armodafinil interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.